Your browser doesn't support javascript.
Variable detection of Omicron-BA.1 and -BA.2 by SARS-CoV-2 rapid antigen tests.
Osterman, Andreas; Badell, Irina; Dächert, Christopher; Schneider, Nikolas; Kaufmann, Anna-Yasemin; Öztan, Gamze Naz; Huber, Melanie; Späth, Patricia M; Stern, Marcel; Autenrieth, Hanna; Muenchhoff, Maximilian; Graf, Alexander; Krebs, Stefan; Blum, Helmut; Czibere, Ludwig; Durner, Jürgen; Kaderali, Lars; Baldauf, Hanna-Mari; Keppler, Oliver T.
  • Osterman A; Max Von Pettenkofer Institute and Gene Center, Virology, National Reference Center for Retroviruses, LMU München, Munich, Germany.
  • Badell I; Max Von Pettenkofer Institute and Gene Center, Virology, National Reference Center for Retroviruses, LMU München, Munich, Germany.
  • Dächert C; Max Von Pettenkofer Institute and Gene Center, Virology, National Reference Center for Retroviruses, LMU München, Munich, Germany.
  • Schneider N; Max Von Pettenkofer Institute and Gene Center, Virology, National Reference Center for Retroviruses, LMU München, Munich, Germany.
  • Kaufmann AY; Max Von Pettenkofer Institute and Gene Center, Virology, National Reference Center for Retroviruses, LMU München, Munich, Germany.
  • Öztan GN; Max Von Pettenkofer Institute and Gene Center, Virology, National Reference Center for Retroviruses, LMU München, Munich, Germany.
  • Huber M; Max Von Pettenkofer Institute and Gene Center, Virology, National Reference Center for Retroviruses, LMU München, Munich, Germany.
  • Späth PM; Max Von Pettenkofer Institute and Gene Center, Virology, National Reference Center for Retroviruses, LMU München, Munich, Germany.
  • Stern M; Max Von Pettenkofer Institute and Gene Center, Virology, National Reference Center for Retroviruses, LMU München, Munich, Germany.
  • Autenrieth H; Max Von Pettenkofer Institute and Gene Center, Virology, National Reference Center for Retroviruses, LMU München, Munich, Germany.
  • Muenchhoff M; Max Von Pettenkofer Institute and Gene Center, Virology, National Reference Center for Retroviruses, LMU München, Munich, Germany.
  • Graf A; German Center for Infection Research (DZIF), Partner Site Munich, Munich, Germany.
  • Krebs S; COVID-19 Registry of the LMU Munich (CORKUM), University Hospital, LMU München, Munich, Germany.
  • Blum H; Laboratory for Functional Genome Analysis, Gene Center, LMU München, Munich, Germany.
  • Czibere L; Laboratory for Functional Genome Analysis, Gene Center, LMU München, Munich, Germany.
  • Durner J; Laboratory for Functional Genome Analysis, Gene Center, LMU München, Munich, Germany.
  • Kaderali L; Labor Becker MVZ GbR, Munich, Germany.
  • Baldauf HM; Labor Becker MVZ GbR, Munich, Germany.
  • Keppler OT; Department of Conservative Dentistry and Periodontology, University Hospital, LMU München, Munich, Germany.
Med Microbiol Immunol ; 2022 Nov 12.
Article in English | MEDLINE | ID: covidwho-2275137
ABSTRACT
During 2022, the COVID-19 pandemic has been dominated by the variant of concern (VoC) Omicron (B.1.1.529) and its rapidly emerging subvariants, including Omicron-BA.1 and -BA.2. Rapid antigen tests (RATs) are part of national testing strategies to identify SARS-CoV-2 infections on site in a community setting or to support layman's diagnostics at home. We and others have recently demonstrated an impaired RAT detection of infections caused by Omicron-BA.1 compared to Delta. Here, we evaluated the performance of five SARS-CoV-2 RATs in a single-centre laboratory study examining a total of 140 SARS-CoV-2 PCR-positive respiratory swab samples, 70 Omicron-BA.1 and 70 Omicron-BA.2, as well as 52 SARS-CoV-2 PCR-negative swabs collected from March 8th until April 10th, 2022. One test did not meet minimal criteria for specificity. In an assessment of the analytical sensitivity in clinical specimen, the 50% limit of detection (LoD50) ranged from 4.2 × 104 to 9.2 × 105 RNA copies subjected to the RAT for Omicron-BA.1 compared to 1.3 × 105 to 1.5 × 106 for Omicron-BA.2. Overall, intra-assay differences for the detection of Omicron-BA.1-containing and Omicron-BA.2-containing samples were non-significant, while a marked overall heterogeneity among the five RATs was observed. To score positive in these point-of-care tests, up to 22-fold (LoD50) or 68-fold (LoD95) higher viral loads were required for the worst performing compared to the best performing RAT. The rates of true-positive test results for these Omicron subvariant-containing samples in the highest viral load category (Ct values < 25) ranged between 44.7 and 91.1%, while they dropped to 8.7 to 22.7% for samples with intermediate Ct values (25-30). In light of recent reports on the emergence of two novel Omicron-BA.2 subvariants, Omicron-BA.2.75 and BJ.1, awareness must be increased for the overall reduced detection rate and marked differences in RAT performance for these Omicron subvariants.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Diagnostic study / Experimental Studies / Prognostic study Topics: Variants Language: English Year: 2022 Document Type: Article Affiliation country: S00430-022-00752-7

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Diagnostic study / Experimental Studies / Prognostic study Topics: Variants Language: English Year: 2022 Document Type: Article Affiliation country: S00430-022-00752-7